Tilray Medical Approved to Bring Critical EU-GMP Quality Testing In-House at Portugal Facility

The approval by INFARMED strengthens the company’s global medical cannabis supply chain, accelerating product releases across regulated markets.

Comments

  • No comments yet.
  • Add a comment